71
Participants
Start Date
December 31, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
December 31, 2016
Gd-EOB-DTPA
"1. Gd-EOB-DTPA enhanced MRI will be obtained within 1 week before, and within 3 to 5 days after surgical resection of the liver.~2. Gd-EOB-DTPA will be administered intravenously with an amount of 0.1mL/kg, 1mL/sec injection rate, followed by saline infusion."
Gd-EOB-DTPA
"1. Gd-EOB-DTPA enhanced MRI will be performed within 3 days of obtaining ICG R15 test.~2. Gd-EOB-DTPA will be administered intravenously with an amount of 0.1mL/kg, 1mL/sec injection rate, followed by saline infusion."
MRI
"1. Gd-EOB-DTPA enhanced MRI will be obtained within 1 week before, and within 3 to 5 days after surgical resection of the liver.~2. Multiphasic MRI including dynamic hepatocyte specific phase will be performed for evaluation of hepatic extraction fraction, with 25 phase dynamic MRI obtained until 30 minutes after contrast injection."
MRI
"1. Gd-EOB-DTPA enhanced MRI will be performed within 3 days of obtaining ICG R15 test.~2. Multiphasic MRI including dynamic hepatocyte specific phase will be performed for evaluation of hepatic extraction fraction, with 25 phase dynamic MRI obtained until 30 minutes after contrast injection."
Cheonnam University Hwasun Hospital, Hwasun-Gun
Asan Medical Center, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Collaborators (2)
Bayer
INDUSTRY
Seoul St. Mary's Hospital
OTHER
Asan Medical Center
OTHER
Chonnam National University Hospital
OTHER
Seoul National University Hospital
OTHER